PPH

Market Vectors Pharmaceutical ETF (the Fund) is a non-diversified investment company. The Fund's investment objective is to seek to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors United States Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest United States listed, publicly traded pharmaceutical companies. The Fund normally invests at least 80% of its total assets in securities that comprise the Fund’s index. The Fund’s investment advisor is Van Eck Associates Corporation. » Full Overview of PPH.A ...

+See More

Here we provide our AYA proprietary alpha stock signals for all premium members on our AYA fintech network platform. Specifically, a high Fama-French multi-factor dynamic conditional alpha suggests that the stock is likely to consistently outperform the broader stock market benchmarks such as S&P 500, Dow Jones, Nasdaq, Russell 3000, MSCI USA, and MSCI World etc. Since March 2023, our proprietary alpha stock signals retain U.S. Patent and Trademark Office (USPTO) fintech patent protection, approval, and accreditation for 20 years. Our homepage and blog articles provide more details on this proprietary alpha stock market investment model with robust long-term historical backtest evidence.

Sharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 1 November 2025